Aristotle Capital Boston’s Amsurg Corp AMSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-152,518
Closed -$10.2M 130
2016
Q3
$10.2M Buy
152,518
+2,290
+2% +$160K 1.82% 8
2016
Q2
$11.6M Sell
150,228
-14,831
-9% -$1.15M 2.26% 1
2016
Q1
$12.3M Buy
165,059
+2,743
+2% +$193K 2.47% 1
2015
Q4
$12.3M Buy
162,316
+19,416
+14% +$1.54M 2.51% 3
2015
Q3
$11.1M Sell
142,900
-9,008
-6% -$695K 2.71% 2
2015
Q2
$10.6M Buy
151,908
+36,421
+32% +$2.43M 2.42% 1
2015
Q1
$7.11M Buy
115,487
+42,212
+58% +$2.44M 2.21% 2
2014
Q4
$4.01M Buy
+73,275
New +$3.74M 2.01% 3

Other funds holding AMSG

Aristotle Capital Boston's AMSG Position: Q4 2016 in Review

Aristotle Capital Boston sold out of Amsurg Corp (AMSG) in Q4 2016, closing a stake of 152,518 shares — an estimated $10.2M sold.

Aristotle Capital Boston first reported a position in AMSG in Q4 2014 and held it in 8 quarters. The position peaked at $12.3M in Q4 2015. 7 funds tracked by Wall St. Rank hold AMSG as of Q4 2016.

  • Aristotle Capital Boston reported no remaining Amsurg Corp position as of Q4 2016 after selling out during the quarter.
  • Aristotle Capital Boston sold 152,518 Amsurg Corp shares in Q4 2016, an estimated $10.2M.
  • Aristotle Capital Boston first reported a position in Amsurg Corp in Q4 2014 and held it in 8 quarters.
  • Aristotle Capital Boston's Amsurg Corp position peaked at $12.3M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Amsurg Corp as of Q4 2016.

Based on Aristotle Capital Boston's 13F filing for Q4 2016, filed 14 Feb 2017.